Retatrutide has balanced agonism at all three receptors, distinguishing it from tirzepatide (dual GIP/GLP-1) and semaglutide (selective GLP-1)
However, Post-marketing surveillance adverse event reports include pancreatic cancer cases Trials only lasted a little more than a year Taking Ozempic could cause pancreatic cancer by stimulating the pancreas or indirectly through pancreatitis
A person experiencing persistent, unmanageable side effects on Ozempic might find relief by switching to Mounjaro, although re-titration from the lowest dose is still required
Semaglutides effect on gastric emptying represents one of the most clinically significant mechanisms for potential drug interactions
If nausea is persistent or severe enough to consistently prevent eating or drinking, it is worth mentioning to a healthcare provider, who may adjust the dose or suggest additional strategies
It justifies monitoring after dose reduction, not because stopping is impossible, but because unobserved drift is common